West Pharmaceutical Services | WST - Current Liabilities

Stock Price
306.16
Daily Change
-3.54 -1.14%
Monthly
23.94%
Yearly
42.70%
Q2 Forecast
267.71

West Pharmaceutical Services reported $674M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Align Technology USD 1.92B 46.45M Dec/2025
Avanos Medical USD 165.2M 17.3M Dec/2025
Baxter International USD 2.97B 805M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Cerus USD 88.43M 4.08M Sep/2025
Charles River Laboratories USD 1.12B 1.57M Dec/2025
Cooper Companies USD 1.6B 482.9M Dec/2025
Dentsply International USD 1.34B 62M Dec/2025
Haemonetics USD 539.87M 8.45M Dec/2025
ICU Medical USD 498.86M 5.96M Dec/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 455.98M 91.93M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
J&J USD 57.72B 3.59B Mar/2026
Medtronic USD 9.5B 440M Dec/2025
Merit Medical Systems USD 239.76M 9.29M Dec/2025
Neogen USD 150.6M 3.55M Dec/2025
OraSure Technologies USD 39.8M 453K Dec/2025
Quidel USD 966.1M 198.2M Dec/2025
Repligen USD 135.83M 4.69M Dec/2025
Rockwell Medical USD 10.95M 259K Jun/2025
Solventum Corp USD 3.14B 198M Dec/2025
STAAR Surgical USD 68.5M 6.87M Dec/2025
Terumo JPY 539.7B 243.4B Dec/2025
Utah Medical Products USD 2.6M 413K Dec/2025
West Pharmaceutical Services USD 674M 19.1M Mar/2026